Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Incidence of pediatric atopic dermatitis following thymectomy: A Danish register study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. 17q21 variant increases the risk of exacerbations in asthmatic children despite inhaled corticosteroids use

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Neonates colonized with pathogenic bacteria in the airways have a low-grade systemic inflammation

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. EAACI guidelines on allergen immunotherapy: Executive statement

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Local recurrence rate in a national Danish patient cohort after curative treatment for rectal cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Circulating allergen-specific T2 lymphocytes: CCR4rather than CLAis the predominant phenotype in peanut-allergic subjects

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  3. Clinical relevance of sensitization to hydrolyzed wheat protein in wheat-sensitized subjects

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Food allergy: setting the scene for tolerance induction

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Association between perfluoroalkyl substance exposure and asthma and allergic disease in children as modified by MMR vaccination

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • G B Pajno
  • M Fernandez-Rivas
  • S Arasi
  • G Roberts
  • C A Akdis
  • M Alvaro-Lozano
  • K Beyer
  • C Bindslev-Jensen
  • W Burks
  • M Ebisawa
  • P Eigenmann
  • E Knol
  • K C Nadeau
  • L K Poulsen
  • R van Ree
  • A F Santos
  • G du Toit
  • S Dhami
  • U Nurmatov
  • Y Boloh
  • M Makela
  • L O'Mahony
  • N Papadopoulos
  • C Sackesen
  • I Agache
  • E Angier
  • S Halken
  • M Jutel
  • S Lau
  • O Pfaar
  • D Ryan
  • G Sturm
  • E-M Varga
  • R G van Wijk
  • A Sheikh
  • A Muraro
  • EAACI Allergen Immunotherapy Guidelines Group
Vis graf over relationer

Food allergy can result in considerable morbidity, impairment of quality of life, and healthcare expenditure. There is therefore interest in novel strategies for its treatment, particularly food allergen immunotherapy (FA-AIT) through the oral (OIT), sublingual (SLIT), or epicutaneous (EPIT) routes. This Guideline, prepared by the European Academy of Allergy and Clinical Immunology (EAACI) Task Force on Allergen Immunotherapy for IgE-mediated Food Allergy, aims to provide evidence-based recommendations for active treatment of IgE-mediated food allergy with FA-AIT. Immunotherapy relies on the delivery of gradually increasing doses of specific allergen to increase the threshold of reaction while on therapy (also known as desensitization) and ultimately to achieve post-discontinuation effectiveness (also known as tolerance or sustained unresponsiveness). Oral FA-AIT has most frequently been assessed: here, the allergen is either immediately swallowed (OIT) or held under the tongue for a period of time (SLIT). Overall, trials have found substantial benefit for patients undergoing either OIT or SLIT with respect to efficacy during treatment, particularly for cow's milk, hen's egg, and peanut allergies. A benefit post-discontinuation is also suggested, but not confirmed. Adverse events during FA-AIT have been frequently reported, but few subjects discontinue FA-AIT as a result of these. Taking into account the current evidence, FA-AIT should only be performed in research centers or in clinical centers with an extensive experience in FA-AIT. Patients and their families should be provided with information about the use of FA-AIT for IgE-mediated food allergy to allow them to make an informed decision about the therapy.

OriginalsprogEngelsk
Artikelnummer4
TidsskriftAllergy
Vol/bindVolume 73
Udgave nummerIssue4
Sider (fra-til)Pages 799-815
Antal sider16
ISSN0105-4538
DOI
StatusUdgivet - apr. 2018

ID: 52696551